---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-091931"
form_type: "8-K"
ticker: "CRBP"
cik: "0001595097"
company_name: "Corbus Pharmaceuticals Holdings, Inc."
filed_at: "2024-08-06T23:59:59+00:00"
generated_at: "2026-05-31T12:16:55.151178+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Corbus files updated corporate presentation; no substantive news identified

## Summary
- Corbus Pharmaceuticals furnished an updated corporate investor presentation on August 6, 2024.
- The filing excerpt does not reveal any specific financial, clinical, or strategic updates.
- The presentation title includes 'Connecting Innovation to Purpose' with no further details provided.
- Given the limited content available, no material new information for investors can be derived.

## SEC filing metadata
- accession: 0000950170-24-091931
- form_type: 8-K
- ticker: CRBP
- cik: 0001595097
- company_name: Corbus Pharmaceuticals Holdings, Inc.
- filed_at: 2024-08-06T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1595097/000095017024091931/0000950170-24-091931-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1595097/000095017024091931/crbp-20240806.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-091931
- JSON: https://secwatch.observer/filing/0000950170-24-091931.json
- Plain text: https://secwatch.observer/filing/0000950170-24-091931.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.